• Je něco špatně v tomto záznamu ?

Associations between HLA class II alleles and type 1 Diabetes Mellitus in the Slovak population

M. Buc, M. Bucova, J. Javor, M. Krivosíkova, M. Stuchlikova, I.Shawkatova I., D. Michalkova, L. Barak, E. Jancova, M. Petrek

. 2006 ; 40 (1) : 1-6.

Jazyk angličtina Země Slovensko

Typ dokumentu srovnávací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19002151

Objectives. Several associations between HLA complex and diabetes mellitus type 1A were found in various groups of patients of Caucasoid population. This study was therefore prompted to be conducted in Slovak population, since any such has not yet been performed in Slovak population. Methods. Patients suffering from DM-1A originated from all regions of Slovakia. Their age ranged from 1 to 42 years; but the criterion for including the subject to the study was the definition of diagnosis in older patients before their age of 15 (Table 1). The diagnosis was set up according to internationally accepted criteria. A total of 460 patients was typed for HLA-DQB1 alleles, among them 97 also for HLA-DQA1 and 146 for HLA-DRB1 alleles. HLA-typing was performed by a PCR-SSP method. Control group consisted of 196 (DQA), 143 (DQB1) and 130 (DRB1) unrelated blood donors aged 19-55 years old irrespective of their age or sex. The data obtained were expressed in a 2 x 2 contingency table and statistical significance was calculated by the Fisher exact test. Results. Among 11 HLA-DQB1 alleles tested DQB1*0302 was the most frequent in DM-1A patients (30.33 % vs. 5.59 % in healthy subjects (HS), followed by DQB1*0201 (22.93 % vs. 12.94 %, respectively). In contrast, the frequency rate of DQB1*0301 (10.66 % vs. 24.48 %), DQB1*0602 (2.17 % vs. 10.14 %) and DQB1*0603 (2.5 % vs. 8,39 %) were decreased in DM-1A patients. Out of 14 DQA1 alleles the highest occurrence rate showed DQA1*0301 (30.93 % VS. 17.09) and DQA1*0501 (34.02 % vs. 25.76 %), while DQA1*0102 (8.76 % vs. 16.58 %) and DQA1*0201(6.18 % vs. 13.51 %7), respectively, were found to be the least frequent. Among 13 HLA-DRB1 alleles tested, the most common occurrence rates showed DRB1*03 (26.37 % vs. 9.62 %) and DRB1*04 (7.19 % vs. 14.23 %), while the least frequent alleles were DRB1*15 (2.74% vs. 12.31 %), DRB1*07 (7.19 % vs. 14.23 %), and DRB1*11 (2.74 % vs. 20.38 %). The alleles DQB1*0302 and DQA1*0301, respectively, were present in the same individual in all DRB1*04 positive patients, suggesting that they belong to the haplotype. Similar situation was observed with the alleles DQB1*0201, DQA1*0501, and DRB*0301, respectively, forming the second HLA haplotype so characteristic for DM1A. For more details on this paper see also “www.elis.sk”.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19002151
003      
CZ-PrNML
005      
20240903122110.0
007      
ta
008      
190111s2006 xo f 000 0|eng||
009      
AR
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Buc, Milan, $d 1944- $7 mzk2006353952 $u Department of Immunology, Comenius University School of Medicine
245    10
$a Associations between HLA class II alleles and type 1 Diabetes Mellitus in the Slovak population / $c M. Buc, M. Bucova, J. Javor, M. Krivosíkova, M. Stuchlikova, I.Shawkatova I., D. Michalkova, L. Barak, E. Jancova, M. Petrek
504    __
$a Literatura
520    3_
$a Objectives. Several associations between HLA complex and diabetes mellitus type 1A were found in various groups of patients of Caucasoid population. This study was therefore prompted to be conducted in Slovak population, since any such has not yet been performed in Slovak population. Methods. Patients suffering from DM-1A originated from all regions of Slovakia. Their age ranged from 1 to 42 years; but the criterion for including the subject to the study was the definition of diagnosis in older patients before their age of 15 (Table 1). The diagnosis was set up according to internationally accepted criteria. A total of 460 patients was typed for HLA-DQB1 alleles, among them 97 also for HLA-DQA1 and 146 for HLA-DRB1 alleles. HLA-typing was performed by a PCR-SSP method. Control group consisted of 196 (DQA), 143 (DQB1) and 130 (DRB1) unrelated blood donors aged 19-55 years old irrespective of their age or sex. The data obtained were expressed in a 2 x 2 contingency table and statistical significance was calculated by the Fisher exact test. Results. Among 11 HLA-DQB1 alleles tested DQB1*0302 was the most frequent in DM-1A patients (30.33 % vs. 5.59 % in healthy subjects (HS), followed by DQB1*0201 (22.93 % vs. 12.94 %, respectively). In contrast, the frequency rate of DQB1*0301 (10.66 % vs. 24.48 %), DQB1*0602 (2.17 % vs. 10.14 %) and DQB1*0603 (2.5 % vs. 8,39 %) were decreased in DM-1A patients. Out of 14 DQA1 alleles the highest occurrence rate showed DQA1*0301 (30.93 % VS. 17.09) and DQA1*0501 (34.02 % vs. 25.76 %), while DQA1*0102 (8.76 % vs. 16.58 %) and DQA1*0201(6.18 % vs. 13.51 %7), respectively, were found to be the least frequent. Among 13 HLA-DRB1 alleles tested, the most common occurrence rates showed DRB1*03 (26.37 % vs. 9.62 %) and DRB1*04 (7.19 % vs. 14.23 %), while the least frequent alleles were DRB1*15 (2.74% vs. 12.31 %), DRB1*07 (7.19 % vs. 14.23 %), and DRB1*11 (2.74 % vs. 20.38 %). The alleles DQB1*0302 and DQA1*0301, respectively, were present in the same individual in all DRB1*04 positive patients, suggesting that they belong to the haplotype. Similar situation was observed with the alleles DQB1*0201, DQA1*0501, and DRB*0301, respectively, forming the second HLA haplotype so characteristic for DM1A. For more details on this paper see also “www.elis.sk”.
650    12
$a diabetes mellitus 1. typu $x genetika $x imunologie $7 D003922
650    _2
$a frekvence genu $7 D005787
650    _2
$a geny MHC třídy II $7 D005802
650    _2
$a genetická vazba $7 D008040
650    _2
$a genetická predispozice k nemoci $7 D020022
650    12
$a HLA-D antigeny $x genetika $x klasifikace $7 D006681
650    _2
$a HLA-DQ antigeny $x genetika $7 D006683
650    _2
$a HLA-DQ alfa řetězec $7 D059848
650    _2
$a HLA-DQ beta řetězec $7 D059866
650    _2
$a HLA-DR antigeny $x genetika $7 D006684
650    _2
$a HLA-DRB1 řetězec $7 D059811
650    _2
$a referenční hodnoty $7 D012016
650    _2
$a dítě $7 D002648
650    _2
$a dospělí $7 D000328
650    _2
$a kojenec $7 D007223
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladiství $7 D000293
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
651    _2
$a Slovenská republika $7 D018154
655    _2
$a srovnávací studie $7 D003160
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bucová, Mária $7 mzk2007390479 $u Department of Immunology, Comenius University School of Medicine
700    1_
$a Javor, Juraj $7 xx0073329 $u Department of Immunology, Comenius University School of Medicine
700    1_
$a Homolová, Monika, $d 1975- $7 xx0322165 $u Department of Immunology, Comenius University School of Medicine
700    1_
$a Stuchlikova, M. $u Department of Immunology, Comenius University School of Medicine
700    1_
$a Shawkatová, Ivana, $d 1968- $7 xx0230777 $u Department of Immunology, Comenius University School of Medicine
700    1_
$a Michalková, Dagmar, $d 1928-2012 $7 nlk20040151638 $u 1st Children Clinic, Comenius University School of Medicine, Bratislava, Slovak Republic
700    1_
$a Barák, Ľubomír $7 xx0070575 $u 1st Children Clinic, Comenius University School of Medicine, Bratislava, Slovak Republic
700    1_
$a Jančová, Emília $7 xx0272755 $u 1st Children Clinic, Comenius University School of Medicine, Bratislava, Slovak Republic
700    1_
$a Petřek, Martin, $d 1963- $7 jn20000401972 $u Department of Immunology, Palacky University School of Medicine, Olomouc, Czech Republic
773    0_
$t Endocrine regulations $x 1210-0668 $g Roč. 40, č. 1 (2006), s. 1-6 $w MED00001518
910    __
$a ABA008 $b A 3699 $c 152 a $y 4 $z 0
990    __
$a 20190111084116 $b ABA008
991    __
$a 20240903122107 $b ABA008
999    __
$a ok $b bmc $g 1366488 $s 1040284
BAS    __
$a 3
BMC    __
$a 2006 $b 40 $c 1 $d 1-6 $i 1210-0668 $m Endocrine regulations $x MED00001518
LZP    __
$c NLK182 $d 20190225 $a NLK 2019-04/pk

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace